Competitive Strategy Analysis of Taiwan Stem Cell Tourism
Date Issued
2011
Date
2011
Author(s)
Chen, Shao-Yin
Abstract
Stem cell tourism is a new term used to describe a situation where legal regulation of stem cell related industry is less clear, therefore private clinics have started to offer stem cell treatment and therefore attracted patients all over the world to seek for medical help, even though some of the procedures are still questionable in terms of safety and efficacy. However, no analysis has been performed to evaluate the global trend of this new industry and how might Taiwan stand in this emerging business opportunities and threats.
In this study, I used PEST (acronym for political, economic, social and technological analysis) to examine the important factors that are affecting this evolving industry. Meanwhile, information on how China, Mexico, and Korea poured investment to meet the demand of international patients is included. I also conducted an analysis to pinpoint the pros and cons of commercialization different types of stem cell products. In addition, value chain analysis is done to elucidate the core and supporting activities of autologous and allogenic stem cell-related treatment. I tried to evaluate the potential of Taiwan in developing stem cell tourism by conducting interviews with Taiwanese stem cell experts, private clinic owner, and Taiwan government officials. The most critical key success factor is concluded on the choice of low risk and focused therapy. Per the results of interview, the most suitable stem cell product and service for the first step development could be autologous fat tissue derived-stem cells for breast augmentation. The most promising way to improve the quality and transparency of stem cell usage relies on reasonable legal control and regulatory design. Collectively, the significance of this study is to form a holistic review for the stem cell business stakeholders who have interest in engaging in Taiwan stem cell tourism industry.
Subjects
Stem cell tourism
competitive analysis
risk management
autologous stem cells
allogenic stem cells
Type
thesis
File(s)![Thumbnail Image]()
Loading...
Name
ntu-100-R99749001-1.pdf
Size
23.32 KB
Format
Adobe PDF
Checksum
(MD5):e1e263f61ca1474cd8fadcadfbfa0b02